SPOTLIGHT: Stem cell therapy for bones nearing human trials

by admin |


An Edinburgh University team of researchers has been using a bioactive scaffold to help spur stem cells to grow into bone or cartilage. The researchers say the approach can be tested in humans in two years for severe trauma. Report

Suggested Articles

Biotech

Cancer biotech Zentalis uncloaks with $85M

Zentalis is coming out of stealth with an $85 million series C, which will propel its lead programs into pivotal trials and broaden its pipeline.

by Amirah Al Idrus
Merck
Biotech

Merck inks $2.7B ArQule deal, teeing up cancer race with Lilly

The planned takeover centers on ARQ 531, a BTK inhibitor that triggered durable responses in patients with B-cell malignancies.

by Nick Paul Taylor
Nurse about to give an infusion
Research

ASH: Amgen's BiTE stalls multiple myeloma relapse in mice

At ASH, Dana-Farber researchers presented promising preclinical data on AMG 701, Amgen's long-lasting BiTE for multiple myeloma, but rivals loom.

by Arlene Weintraub